These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4645223)

  • 1. Studies on metabolism of drugs. 13. Quantitative separation of metabolites in human urine after oral administration of sulfisomezole and sulfaphenazole.
    Ueda M; Orita K; Koizumi T
    Chem Pharm Bull (Tokyo); 1972 Sep; 20(9):2047-50. PubMed ID: 4645223
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on metabolism of drugs. X. New metabolite of sulfisomezole in man.
    Ueda M; Takegoshi I; Koizumi T
    Chem Pharm Bull (Tokyo); 1971 Oct; 19(10):2041-5. PubMed ID: 5137274
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on metabolism of drugs. XI. A new metabolite of sulfaphenazole in man.
    Ueda M; Orita K; Koizumi T
    Chem Pharm Bull (Tokyo); 1971 Oct; 19(10):2046-9. PubMed ID: 5137275
    [No Abstract]   [Full Text] [Related]  

  • 4. High pressure liquid chromatographic analysis and preliminary pharmacokinetics of sulfaphenazole and its N2-glucuronide and N4-acetyl metabolites in plasma and urine of man.
    Vree TB; Beneken Kolmer EW; Hekster YA
    Pharm Weekbl Sci; 1990 Dec; 12(6):243-6. PubMed ID: 2091020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on drug metabolites by mass spectrometry. II. Identification of urinary metabolites of sulfisomezole].
    Tatematsu A; Nadai T; Yoshizumi H
    Yakugaku Zasshi; 1972 Jun; 92(6):655-60. PubMed ID: 5066364
    [No Abstract]   [Full Text] [Related]  

  • 6. Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers.
    Veronese ME; Miners JO; Randles D; Gregov D; Birkett DJ
    Clin Pharmacol Ther; 1990 Mar; 47(3):403-11. PubMed ID: 2311340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of the combined preparation trimezol--Farmakhim. 1. Plasma levels and urinary excretion of trimethoprim and sulfamethoxazole in the rat].
    Mikhailova D; Mikhaĭlova T; Bogoslovova T; Raĭnova L; Staneva D
    Eksp Med Morfol; 1983; 22(4):23-8. PubMed ID: 6609062
    [No Abstract]   [Full Text] [Related]  

  • 8. Absorption and urinary execretion of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole: results with single doses in normal young adults and preliminary observations during therapy with trimethoprim-sulfamethoxazole.
    Bach MC; Gold O; Finland M
    J Infect Dis; 1973 Nov; 128():Suppl:584-99 p. PubMed ID: 4758050
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man.
    Kaplan SA; Weinfeld RE; Abruzzo CW; McFaden K; Jack ML; Weissman L
    J Infect Dis; 1973 Nov; 128():Suppl:547-55 p. PubMed ID: 4758045
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibacterial activity in human urine of fosfomycin trometamol in an in vitro model of the urinary bladder.
    Dubini F; Riviera L
    Chemioterapia; 1988 Feb; 7(1):15-9. PubMed ID: 3259909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on metabolism of drugs. XII. Quantitative separation of metabolites in human and rabbit urine after oral administration of sulfamonomethoxine and sulfamethomidine.
    Ueda M; Tsurui Y; Koizumi T
    Chem Pharm Bull (Tokyo); 1972 Sep; 20(9):2042-6. PubMed ID: 4645222
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on metabolism of drugs. VII. On the metabolite of sulfamonomethoxine in humans].
    Ueda M; Murakami N; Atsumura H; Huruki K
    Yakugaku Zasshi; 1967 Apr; 87(4):455-7. PubMed ID: 5624145
    [No Abstract]   [Full Text] [Related]  

  • 13. (STUDIES ON METABOLISM OF DRUGS. V. ON THE NEW METABOLITE OF SULFISOMEZOLE IN HUMAN.).
    UEDA M; KURIBAYASHI K
    Yakugaku Zasshi; 1964 Nov; 84():1104-7. PubMed ID: 14265134
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of trimethoprim and sulfamethoxazole in normal subjects and in patients with renal failure.
    Welling PG; Craig WA; Amidon GL; Kunin CM
    J Infect Dis; 1973 Nov; 128():Suppl:556-66 p. PubMed ID: 4758046
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intermittent parenteral treatment of trachoma with sulfaphenazole].
    Aubry M
    Rev Int Trach; 1966; 43(2):101-31. PubMed ID: 5930435
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares.
    Brown MP; Gronwall R; Castro L
    Am J Vet Res; 1988 Jun; 49(6):918-22. PubMed ID: 3261143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole: pharmacodynamic effects of urinary pH and impaired renal function. Studies in humans.
    Craig WA; Kunin CM
    Ann Intern Med; 1973 Apr; 78(4):491-7. PubMed ID: 4571565
    [No Abstract]   [Full Text] [Related]  

  • 18. The hydroxylamine of sulfamethoxazole and adverse reactions in patients with acquired immunodeficiency syndrome.
    Lee BL; Delahunty T; Safrin S
    Clin Pharmacol Ther; 1994 Aug; 56(2):184-9. PubMed ID: 8062495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfaphenazole treatment restores endothelium-dependent vasodilation in diabetic mice.
    Elmi S; Sallam NA; Rahman MM; Teng X; Hunter AL; Moien-Afshari F; Khazaei M; Granville DJ; Laher I
    Vascul Pharmacol; 2008 Jan; 48(1):1-8. PubMed ID: 17974492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients.
    Giannarelli C; Virdis A; De Negri F; Magagna A; Duranti E; Salvetti A; Taddei S
    Circulation; 2009 Mar; 119(12):1625-33. PubMed ID: 19289643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.